Variant report
Variant | esv3400100 |
---|---|
Chromosome Location | chr6:55228042-55250271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537063250 | chr6:55233820-55233821 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186863221 | chr6:55233841-55233842 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556909444 | chr6:55233848-55233849 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573931967 | chr6:55233881-55233882 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536789627 | chr6:55233899-55233900 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553185004 | chr6:55233911-55233912 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556036074 | chr6:55233914-55233915 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573042633 | chr6:55233915-55233916 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374822329 | chr6:55233926-55233927 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369524884 | chr6:55233933-55233934 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371569779 | chr6:55233939-55233940 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575579644 | chr6:55233945-55233946 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544617575 | chr6:55233946-55233947 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544495289 | chr6:55233948-55233949 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560971702 | chr6:55233962-55233963 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140084900 | chr6:55233964-55233965 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369671398 | chr6:55233965-55233966 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149790933 | chr6:55233968-55233969 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540708647 | chr6:55233981-55233982 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373064691 | chr6:55233990-55233991 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191700773 | chr6:55233996-55233997 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551526606 | chr6:55234012-55234013 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560429411 | chr6:55234015-55234016 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537378553 | chr6:55234019-55234020 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550977687 | chr6:55234034-55234035 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145749459 | chr6:55234050-55234051 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113706996 | chr6:55234061-55234062 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186075294 | chr6:55234079-55234080 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190888834 | chr6:55234082-55234083 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529109472 | chr6:55234095-55234096 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148937720 | chr6:55234102-55234103 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544556957 | chr6:55234111-55234112 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561021315 | chr6:55234112-55234113 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574377319 | chr6:55234113-55234114 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182339856 | chr6:55234122-55234123 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560208446 | chr6:55234130-55234131 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532051118 | chr6:55234145-55234146 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12111144 | chr6:55234152-55234153 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527844531 | chr6:55234159-55234160 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531002410 | chr6:55234165-55234166 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187814988 | chr6:55234172-55234173 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs4712101 | chr6:55234173-55234174 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536663184 | chr6:55234177-55234178 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546646902 | chr6:55234184-55234185 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566848552 | chr6:55234201-55234202 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539168320 | chr6:55234204-55234205 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531470547 | chr6:55234205-55234206 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192756788 | chr6:55234207-55234208 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs11757181 | chr6:55234217-55234218 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs146777368 | chr6:55234218-55234219 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:55233800-55234400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
2 | chr6:55234000-55234200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:55234000-55234400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
4 | chr6:55234000-55234400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:55234600-55235000 | Enhancers | Spleen | Spleen |
6 | chr6:55235000-55235400 | Weak transcription | Spleen | Spleen |
7 | chr6:55235400-55235800 | Enhancers | Spleen | Spleen |
8 | chr6:55248400-55248600 | Enhancers | Fetal Lung | lung |
9 | chr6:55248600-55249600 | Weak transcription | Fetal Lung | lung |
10 | chr6:55249600-55250200 | Enhancers | Fetal Lung | lung |